The FDA approved a new one-pill formulation of the emergency contraceptive Plan B in July.
The Food and Drug Administration (FDA) approved a new one-pill formulation of the emergency contraceptive (EC) Plan B in July. Called Plan B One-Step, the product is available behind the counter without a prescription to women 17 or older. The FDA also recently approved Next Choice, a generic version of the original two-pill Plan B formulation, which is obtainable by prescription to those 17 or younger.
The American College of Obstetricians and Gynecologists (ACOG) praised the recent FDA actions, saying the new formulation "will simplify this important pregnancy prevention treatment" (ACOG press release, 7/15/09). However, ACOG also reiterated its "long-held position that there is no valid scientific or medical reason to impose an age restriction on the availability of EC because it is safe and effective for adolescents and women of all ages." It urged the FDA "to withdraw the age restriction altogether and eliminate the behind-the-counter status for EC."
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More